The global injectable drug delivery devices market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing number of patients suffering from chronic diseases such as cancer and diabetes, which require regular injections for treatment. In addition, the increasing awareness about self-injection among patients has also led to an increase in demand for injectable drug delivery devices. The global injectable drug delivery devices market by type is segmented into devices and formulation. The formulation segment accounted for a share of over 60% in 2017 and is expected to maintain its dominance throughout the forecast period owing to its wide range of applications across various therapeutic areas such as immune disorders, cancer, diabetes etc, which are driving its growth globally.
- Injectable drug delivery devices are used for administering drugs that cannot be taken orally or through other routes such as inhalation or topical application due to their chemical properties and therapeutic effects on the body.
- Injectable drug delivery devices are also used for treating conditions such as cancer, arthritis, asthma, and diabetes among others which are major drivers of growth in this market segment over the forecast period (2017-2022) 5) Increasing awareness about these products among physicians and patients is also expected to fuel growth in this market segment over the forecast period (2017-2022).
Industry Growth Insights published a new data on “Injectable Drug Delivery Devices Market”. The research report is titled “Injectable Drug Delivery Devices Market research by Types (Devices, Formulation), By Applications (Immune Disorder, Cancer, Diabetes, Other), By Players/Companies Dickinson and Company, Baxter International, Schott, Eli Lilly, Pfizer, Gerresheimer, Terumo Corporation, Antares Pharma, Novo Nordik, Sanofi, Unilife Corporation, Zogenix, Hospira, Presage Bioscience, MicroCHIPS, Pearl Therapeutics, Genentech, Bend Research”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Injectable Drug Delivery Devices Market Research Report
By Type
Devices, Formulation
By Application
Immune Disorder, Cancer, Diabetes, Other
By Companies
Dickinson and Company, Baxter International, Schott, Eli Lilly, Pfizer, Gerresheimer, Terumo Corporation, Antares Pharma, Novo Nordik, Sanofi, Unilife Corporation, Zogenix, Hospira, Presage Bioscience, MicroCHIPS, Pearl Therapeutics, Genentech, Bend Research
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Injectable Drug Delivery Devices Market Report Segments:
The global Injectable Drug Delivery Devices market is segmented on the basis of:
Types
Devices, Formulation
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Immune Disorder, Cancer, Diabetes, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Dickinson and Company
- Baxter International
- Schott
- Eli Lilly
- Pfizer
- Gerresheimer
- Terumo Corporation
- Antares Pharma
- Novo Nordik
- Sanofi
- Unilife Corporation
- Zogenix
- Hospira
- Presage Bioscience
- MicroCHIPS
- Pearl Therapeutics
- Genentech
- Bend Research
Highlights of The Injectable Drug Delivery Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Devices
- Formulation
- By Application:
- Immune Disorder
- Cancer
- Diabetes
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Injectable Drug Delivery Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Injectable drug delivery devices are medical devices that are inserted into a person's body to deliver medications. They can be used to inject drugs directly into the bloodstream, or they can be used to pump drugs directly into a specific area of the body.
Some of the key players operating in the injectable drug delivery devices market are Dickinson and Company, Baxter International, Schott, Eli Lilly, Pfizer, Gerresheimer, Terumo Corporation, Antares Pharma, Novo Nordik, Sanofi, Unilife Corporation, Zogenix, Hospira, Presage Bioscience, MicroCHIPS, Pearl Therapeutics, Genentech, Bend Research.
The injectable drug delivery devices market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Injectable Drug Delivery Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Injectable Drug Delivery Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Injectable Drug Delivery Devices Market - Supply Chain
4.5. Global Injectable Drug Delivery Devices Market Forecast
4.5.1. Injectable Drug Delivery Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Injectable Drug Delivery Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Injectable Drug Delivery Devices Market Absolute $ Opportunity
5. Global Injectable Drug Delivery Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Injectable Drug Delivery Devices Market Size and Volume Forecast by Type
5.3.1. Devices
5.3.2. Formulation
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Injectable Drug Delivery Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Injectable Drug Delivery Devices Market Size and Volume Forecast by Application
6.3.1. Immune Disorder
6.3.2. Cancer
6.3.3. Diabetes
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Injectable Drug Delivery Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Injectable Drug Delivery Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Injectable Drug Delivery Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Injectable Drug Delivery Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Injectable Drug Delivery Devices Demand Share Forecast, 2019-2026
9. North America Injectable Drug Delivery Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Injectable Drug Delivery Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Injectable Drug Delivery Devices Market Size and Volume Forecast by Application
9.4.1. Immune Disorder
9.4.2. Cancer
9.4.3. Diabetes
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Injectable Drug Delivery Devices Market Size and Volume Forecast by Type
9.7.1. Devices
9.7.2. Formulation
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Injectable Drug Delivery Devices Demand Share Forecast, 2019-2026
10. Latin America Injectable Drug Delivery Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Injectable Drug Delivery Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Injectable Drug Delivery Devices Market Size and Volume Forecast by Application
10.4.1. Immune Disorder
10.4.2. Cancer
10.4.3. Diabetes
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Injectable Drug Delivery Devices Market Size and Volume Forecast by Type
10.7.1. Devices
10.7.2. Formulation
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Injectable Drug Delivery Devices Demand Share Forecast, 2019-2026
11. Europe Injectable Drug Delivery Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Injectable Drug Delivery Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Injectable Drug Delivery Devices Market Size and Volume Forecast by Application
11.4.1. Immune Disorder
11.4.2. Cancer
11.4.3. Diabetes
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Injectable Drug Delivery Devices Market Size and Volume Forecast by Type
11.7.1. Devices
11.7.2. Formulation
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Injectable Drug Delivery Devices Demand Share, 2019-2026
12. Asia Pacific Injectable Drug Delivery Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Injectable Drug Delivery Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Injectable Drug Delivery Devices Market Size and Volume Forecast by Application
12.4.1. Immune Disorder
12.4.2. Cancer
12.4.3. Diabetes
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Injectable Drug Delivery Devices Market Size and Volume Forecast by Type
12.7.1. Devices
12.7.2. Formulation
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Injectable Drug Delivery Devices Demand Share, 2019-2026
13. Middle East & Africa Injectable Drug Delivery Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Injectable Drug Delivery Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Injectable Drug Delivery Devices Market Size and Volume Forecast by Application
13.4.1. Immune Disorder
13.4.2. Cancer
13.4.3. Diabetes
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Injectable Drug Delivery Devices Market Size and Volume Forecast by Type
13.7.1. Devices
13.7.2. Formulation
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Injectable Drug Delivery Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Injectable Drug Delivery Devices Market: Market Share Analysis
14.2. Injectable Drug Delivery Devices Distributors and Customers
14.3. Injectable Drug Delivery Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Dickinson and Company
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Baxter International
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Schott
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Eli Lilly
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Pfizer
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Gerresheimer
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Terumo Corporation
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Antares Pharma
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Novo Nordik
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Sanofi
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Unilife Corporation
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Zogenix
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Hospira
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Presage Bioscience
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. MicroCHIPS
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Pearl Therapeutics
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Genentech
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Bend Research
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook